Transparency Market Research

Global H1N1 Vaccination Market Fueled by Recent Outbreaks of Swine Flu

Transparency Market Research Report Added "H1N1 Vaccination Market" to its database.


Albany, NY -- (SBWIRE) -- 12/31/2015 -- Transparency Market Research's report, titled "H1N1 Vaccination Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023," highlights the leading factors driving the global H1N1 vaccination market and sheds light on the various challenges that it faces during the forecast period of 2015 to 2023.

According to the Centers for Disease Control and Prevention's (CDC) Influenza Division, an estimated 151,700 to 575,400 people died from the 2009 H1N1 virus infection. People in Africa and Southeast Asia were the most adversely affected owing to limited prevention and treatment resources. An estimated 80.0% of the people who died in that outbreak were below the age of 65. This massive infection outbreak, followed by increased efforts to prevent it from occurring again, is the most significant factor fueling the demand for H1N1 vaccination.

Read Full Report:

The global H1N1 vaccination market is geographically divided into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In terms of revenue, Europe and North America are the leading markets for H1N1 vaccination mainly owing to the presence of developed and advanced research infrastructure. While France and Germany are the major countries in the Europe H1N1 vaccination market, the U.S. and Canada are prominent markets for H1N1 vaccination in North America.

Asia Pacific is projected to emerge as a strong contender in the coming years and exhibit a strong growth by the end of the forecast period. This can be attributed to the rising H1N1 cases in the region, especially in India. Favorable government initiatives and programs to curb the spread of the infectious disease and growing awareness among the masses drive the H1N1 vaccination market in Asia Pacific. Another factor that is anticipated to propel this regional market is establishment of new companies and the expansion of prominent players. Aspects such as a large patient and talent pool; low cost of labor; growing medical infrastructure; less stringent health, safety, and environmental laws; and developing economies have succeeded in attracting companies invested in H1N1 vaccination. Advancements in the field of biomedical science and discovery of new vaccines also offer strong opportunities to market players.

Get Free Sample:

The research report includes a detailed section on the H1N1 vaccination vendor landscape. The report identifies the key players competing within the global market and reviews them based on attributes such as company and financial overview, recent developments, business strategies, and product portfolio. With the help of a SWOT analysis, the report highlights individual players' strengths, weaknesses, opportunities, and threats. Porter's Five Forces analysis sheds light on the impact of buyers, suppliers, competitors, new entrants, and substitutes on each player.

The leading players operating in the H1N1 vaccination market include Sinovac, GlaxoSmithKline, Baxter, Medimmune, Sanofi Pasteur, Novartis, and Commonwealth Serum Laboratories (CSL).

Read Full Report on Healthcare IT Market:

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453